The chemical class of PAC4 Activators largely comprises compounds that influence the intracellular levels of cyclic AMP (cAMP), a secondary messenger intimately connected to PAC4 signaling. This class includes adenylyl cyclase activators, phosphodiesterase inhibitors, and agonists of various receptors that ultimately raise cAMP levels. Forskolin, a diterpene from the Indian coleus plant, directly stimulates adenylyl cyclase, enhancing cAMP production and thereby potentially upregulating PAC4 activity. Phosphodiesterase inhibitors like IBMX, Rolipram, Cilostamide, and Milrinone, indirectly supporting PAC4 signaling.
Additionally, receptor agonists like Epinephrine, Dopamine, PGE2, Histamine, Salbutamol, Terbutaline, and Isoproterenol operate through G-protein coupled receptors (GPCRs) that influence cAMP levels. For instance, Epinephrine, through beta-adrenergic receptors, and Histamine, via H2 receptors, trigger pathways leading to increased cAMP. This elevated cAMP can indirectly enhance PAC4 activity, as PAC4 signaling is modulated by cAMP levels. The broad range of these chemicals reflects the diverse physiological contexts in which PAC4 functions, from neurotransmitter release to insulin secretion.Understanding the intricate relationship between these activators and PAC4 is crucial for comprehending the physiological and pathophysiological roles of this receptor. The use of these activators can provide valuable insights into the regulation of PAC4 and its associated cellular processes, highlighting the importance of cAMP as a key mediator in PAC4 signaling pathways.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, leading to increased cAMP levels which can enhance PAC4 signaling. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
Rolipram, a selective inhibitor of phosphodiesterase 4 (PDE4), increases cAMP in cells, thereby potentially augmenting PAC4 signaling. | ||||||
Cilostamide (OPC 3689) | 68550-75-4 | sc-201180 sc-201180A | 5 mg 25 mg | $90.00 $350.00 | 16 | |
Cilostamide is a selective inhibitor of PDE3, which leads to increased cAMP levels, possibly enhancing PAC4 activity. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $40.00 $102.00 $197.00 $1739.00 $16325.00 | ||
Epinephrine can activate beta-adrenergic receptors, leading to elevated cAMP, which may indirectly stimulate PAC4. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Dopamine, through its action on dopamine receptors, can increase cAMP in certain neuronal cells, potentially influencing PAC4 activity. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $56.00 $156.00 $270.00 $665.00 | 37 | |
PGE2, via its action on EP receptors, can increase cAMP levels in various cells, potentially affecting PAC4 signaling. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $92.00 $277.00 $969.00 | 7 | |
Histamine, through H2 receptor activation, increases cAMP levels, which might indirectly enhance PAC4 activity. | ||||||
Salbutamol | 18559-94-9 | sc-253527 sc-253527A | 25 mg 50 mg | $92.00 $138.00 | ||
Salbutamol, a beta2-adrenergic agonist, elevates cAMP levels, potentially influencing PAC4 signaling. | ||||||
Terbutaline Hemisulfate | 23031-32-5 | sc-204911 sc-204911A | 1 g 5 g | $90.00 $371.00 | 2 | |
Terbutaline, another beta2-adrenergic agonist, increases cAMP levels, which may indirectly activate PAC4. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
Isoproterenol, a non-selective beta-adrenergic agonist, raises cAMP levels, potentially affecting PAC4 activity. | ||||||